Immunai is a biotechnology company that develops single-cell immune profiling and computational platforms to map the human immune system. The company combines high-throughput single-cell assays, multi-omic data integration, and machine-learning analytics to identify immune cell states, biomarkers, and therapeutic targets for drug discovery and translational research partnerships.
Leadership & Board
Current Number of Employees179
Current LinkedIn Followers26,810
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$215M
Total Amount Raised$215M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$215M
Latest Funding Amount$215M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation―
Post-Money Valuation―
Company Momentum Positive
Articles Published on TipRanks3
Articles Published on TipRanks
3
LinkedIn Trend+0.45% followers
LinkedIn Trend
+0.45% followers
Workforce Trend1.1% employees
Workforce Trend
1.1% employees
Immunai LinkedIn following is increasing, signaling rising market interest, while its workforce size remains relatively unchanged.
Company Momentum indicates whether the company is gaining or losing traction over time. This proprietary TipRanks metric analyzes changes in a company’s workforce and LinkedIn follower trends, balancing these signals together to generate an overall momentum sentiment.
Employee Trend
Immunai had 179 employees as of May 25, 2026. The number of employees decreased by 2 (1.10%) week-over-week.
179Latest Employee Count
2(-1.10%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Immunai had 26,810 followers as of May 25, 2026. The number of followers increased by 119 (0.45%) week-over-week.
26,810Latest Followers Count
119(0.45%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.
Funding Round
Nov 27, 2021
Series B
$215.00M
―
Investors
Series B
